Find Licofelone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 156897-06-2, Ml-3000, Licofelone [inn], Ml 3000, 2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid, P5t6bys22y
Molecular Formula
C23H22ClNO2
Molecular Weight
379.9  g/mol
InChI Key
UAWXGRJVZSAUSZ-UHFFFAOYSA-N
FDA UNII
P5T6BYS22Y

Licofelone
Developed by the German pharmaceutical company, Merckle GmbH, together with EuroAlliance partners Alfa Wassermann and Lacer, licofelone (ML3000) is a dual COX/LOX inhibitor and the first member of this new class of analgesic and anti-inflammatory drugs. It is currently under evaluation as a treatment for osteoarthritis (OA), the most common form of arthritis. Although phase III trials have been successfully completed in OA patients no dates for regulatory submission have yet been given.
1 2D Structure

Licofelone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid
2.1.2 InChI
InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)
2.1.3 InChI Key
UAWXGRJVZSAUSZ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C
2.2 Other Identifiers
2.2.1 UNII
P5T6BYS22Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl)acetic Acid

2. Ml 3000

3. Ml-3000

2.3.2 Depositor-Supplied Synonyms

1. 156897-06-2

2. Ml-3000

3. Licofelone [inn]

4. Ml 3000

5. 2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic Acid

6. P5t6bys22y

7. (6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl)acetic Acid

8. [6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl]acetic Acid

9. Chembl300982

10. 2-(6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl)acetic Acid

11. Lcf

12. 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl]acetic Acid

13. Unii-p5t6bys22y

14. Brn 6823674

15. 6-(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-1h-pyrrolizine-5-acetic Acid

16. 2,2-dimethyl-6-(4-chlorophenyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl)acetic Acid

17. 2,3-dihydro-6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-1h-pyrrolizine-5-acetic Acid

18. Licofelone [mi]

19. Licofelone [mart.]

20. Mls006011224

21. Schembl237833

22. Dtxsid40166154

23. Hms3655d21

24. Bcp06598

25. Hy-b1452

26. Zinc3805769

27. Bdbm50038649

28. Ml3000

29. S2121

30. Akos027250758

31. Db04725

32. Sb19520

33. (6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl)-acetic Acid

34. 1h-pyrrolizine-5-acetic Acid, 2,3-dihydro-6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-

35. Ncgc00250374-01

36. Ncgc00250374-02

37. Ac-33111

38. As-73938

39. Smr004702985

40. Cs-0013159

41. Ft-0670787

42. Sw219543-1

43. Ab01566204_02

44. 897l062

45. A809783

46. J-009352

47. Q3832015

48. [2-(4-chloro-phenyl)-6,6-dimethyl-1-phenyl-6,7-dihydro-5h-pyrrolizin-3-yl]-acetic Acid

49. 1h-pyrrolizine-5-acetic Acid, 6-(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-

50. 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic Acid

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 379.9 g/mol
Molecular Formula C23H22ClNO2
XLogP35.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass379.1339066 g/mol
Monoisotopic Mass379.1339066 g/mol
Topological Polar Surface Area42.2 Ų
Heavy Atom Count27
Formal Charge0
Complexity537
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For the management of osteoarthritis.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Licofelone belongs to a novel class of dual-acting anti-inflammatory drugs called COX/LO inhibitors. This group of drugs simultaneously inhibits the enzymes cyclooxygenase (COX) and 5-lipoxygenase (LO).


5.2 MeSH Pharmacological Classification

Cyclooxygenase Inhibitors

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)


Analgesics

Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)


Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


Lipoxygenase Inhibitors

Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)


5.3 Metabolism/Metabolites

Licofelone has known human metabolites that include (2S,3S,4S,5R)-6-[2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid, Licofelone M2, and Licofelone M4.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.4 Mechanism of Action

Licofelone, through combined 5-LOX/COX-inhibition, reduces levels of inflammatory prostaglandins and leukotrienes.


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty